Target intelligence / Profile preview

DNA polymerase beta and DNA replication polymerases (Pol β, Pol α, Pol δ, Pol ε)

Target
Pol β, Pol α, Pol δ, Pol ε
Molecular classification
Enzyme, Transferase, DNA polymerase
01

Overview

DNA polymerase beta (Pol β) and the replication-associated DNA polymerases (alpha, delta, and epsilon) are essential enzymes responsible for synthesizing DNA strands and maintaining genomic integrity. Pol β is a specialized enzyme primarily involved in the base excision repair (BER) pathway, where it fills short gaps in DNA following the removal of damaged bases (Beard & Wilson, 2006). In contrast, DNA polymerases alpha, delta, and epsilon are the primary engines of nuclear DNA replication, coordinating the synthesis of leading and lagging strands during the S-phase of the cell cycle (Burgers & Kunkel, 2017). These enzymes are critical therapeutic targets in oncology, as their inhibition can lead to DNA damage accumulation, cell cycle arrest, and apoptosis in rapidly dividing cancer cells (UniProt Consortium, 2024). Many chemotherapeutic agents, such as nucleoside analogs like Cytarabine and Gemcitabine, function by competing with natural nucleotides for incorporation by these polymerases or by directly inhibiting their catalytic activity (National Cancer Institute, 2023). Because this target entry aggregates multiple distinct enzymes with different primary biological roles, it is classified as containing too much information for a single canonical target profile.

Other names
DNA-directed DNA polymeraseDNA nucleotidyltransferasePOLBPOLA1POLD1POLEDNA polymerase alphaDNA polymerase deltaDNA polymerase epsilon
02

Mechanism of action

Inhibition of DNA synthesis through competitive binding with deoxyribonucleotide triphosphates (dNTPs) or induction of DNA chain termination upon incorporation into the nascent DNA strand (National Cancer Institute, 2023).

03

Biological functions

DNA replicationDNA repairBase excision repairGenome stabilityGap-filling DNA synthesis
04

Disease associations

CancerViral infectionGenetic instabilityNeurodegenerative disease
05

Safety considerations

MyelosuppressionGastrointestinal toxicityGenotoxicityPotential for mitochondrial toxicity if cross-reactivity occurs with DNA polymerase gammaSecondary malignancies
06

Interacting drugs

Cytarabine

7 more in the full profile.

07

Biomarkers

Pol β expression levelsProliferating cell nuclear antigen (PCNA)Microsatellite instability (MSI)Ki-67 proliferation index

Beyond the preview

Go deeper on DNA polymerase beta and DNA replication polymerases (Pol β, Pol α, Pol δ, Pol ε).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase beta and DNA replication polymerases (Pol β, Pol α, Pol δ, Pol ε).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call